全文获取类型
收费全文 | 1668篇 |
免费 | 122篇 |
国内免费 | 113篇 |
专业分类
耳鼻咽喉 | 1篇 |
儿科学 | 63篇 |
妇产科学 | 14篇 |
基础医学 | 136篇 |
口腔科学 | 24篇 |
临床医学 | 315篇 |
内科学 | 377篇 |
皮肤病学 | 41篇 |
神经病学 | 131篇 |
特种医学 | 363篇 |
外国民族医学 | 1篇 |
外科学 | 45篇 |
综合类 | 40篇 |
预防医学 | 62篇 |
眼科学 | 12篇 |
药学 | 218篇 |
中国医学 | 1篇 |
肿瘤学 | 59篇 |
出版年
2022年 | 6篇 |
2021年 | 9篇 |
2020年 | 10篇 |
2019年 | 15篇 |
2018年 | 17篇 |
2017年 | 13篇 |
2016年 | 29篇 |
2015年 | 24篇 |
2014年 | 30篇 |
2013年 | 41篇 |
2012年 | 30篇 |
2011年 | 44篇 |
2010年 | 58篇 |
2009年 | 54篇 |
2008年 | 29篇 |
2007年 | 77篇 |
2006年 | 47篇 |
2005年 | 70篇 |
2004年 | 29篇 |
2003年 | 35篇 |
2002年 | 28篇 |
2001年 | 31篇 |
2000年 | 41篇 |
1999年 | 35篇 |
1998年 | 93篇 |
1997年 | 99篇 |
1996年 | 106篇 |
1995年 | 65篇 |
1994年 | 65篇 |
1993年 | 67篇 |
1992年 | 34篇 |
1991年 | 47篇 |
1990年 | 45篇 |
1989年 | 62篇 |
1988年 | 46篇 |
1987年 | 58篇 |
1986年 | 35篇 |
1985年 | 52篇 |
1984年 | 24篇 |
1983年 | 18篇 |
1982年 | 27篇 |
1981年 | 23篇 |
1980年 | 32篇 |
1979年 | 9篇 |
1978年 | 11篇 |
1977年 | 16篇 |
1976年 | 26篇 |
1975年 | 16篇 |
1971年 | 4篇 |
1970年 | 5篇 |
排序方式: 共有1903条查询结果,搜索用时 254 毫秒
121.
Emphysema in the renal allograft 总被引:1,自引:0,他引:1
Two diabetic patients in whom emphysematous pyelonephritis developed after renal transplantation are described. Clinical recognition of this unusual and serious infection is masked by the effects of immunosuppression. Abdominal radiographic, ultrasound, and computed tomography findings are discussed. The clinical presentation includes urinary tract infection, sepsis, and acute tubular malfunction of the allograft in insulin-dependent diabetics. 相似文献
122.
A Eschalier J L Montastruc J L Devoize F Rigal G Gaillard-Plaza J C Pechadre 《European journal of pharmacology》1981,74(1):1-7
The effects of the tricyclic antidepressant clomipramine were studied in two analgesic tests in rats: (1) vocalization threshold response; and (2) scored behavioral response to electric shock to the tail. Clomipramine (20-50 mg/kg i.p.) produced analgesia, decreasing behavioral response scores and increasing vocalization threshold. Morphine also reduced the response scores in the second test. Naloxone (0.8 mg/kg i.p) or methysergide (20 mg/kg i.p.) (no effect when given alone) abolished the analgesic effect of clomipramine as evaluated by vocalization threshold response. Naloxone alone (0.6 or 2 mg/kg i.p.) increased the behavioral response at 20 and 30 V but did not modify the score at 40 V. Naloxone reduced the analgesic effect of clomipramine or morphine in the behavioral test. These results suggest that the analgesic effect of clomipramine could involve both serotonergic and endorphin central systems. 相似文献
123.
124.
125.
OBJECTIVE: To investigate the risk of falls associated with drugs among the French population using data reported to the French spontaneous reporting system and recorded in the French Pharmacovigilance database. METHODS: All cases including a fall were searched in the French Pharmacovigilance database between 1995 and 1999. Drugs involved and characteristics of patients were investigated. In a second step, we estimated the risk associated with psychotropic and cardiovascular drugs in a case/non case comparison, where cases were reports including a fall and non cases all other reports. This risk was estimated by calculation of crude and age and gender adjusted reporting odds ratios (ROR). RESULTS: During this period, 328 reports including a fall were reported (0.4% of the database). Patients were female in 70%. Mean age was 76 +/- 18 years. Comparisons between cases and non cases showed that cases were more likely to be women (OR: 1.9; 95% confidence interval (CI) [1.5-2.4]) and older. After adjustment on age and gender, falls remained significantly associated with exposure to benzodiazepines (4.7 [3.7-5.9]), imipraminic antidepressants (3.6 [2.5-5.1]), serotonin reuptake inhibitor (SRI) antidepressants (2.2 [1.5-3.1]) or nitrates (1.9 [1.2-2.8]). CONCLUSION: This study confirms that taking psychotropic drugs strongly increases the risk of falls. The role of cardiovascular drugs (except nitrates) remains not significant when confounding factors are taken into account. According to the very high prevalence of psychotropic drug use in the French elderly, further study are needed to investigate the relative effect of some drugs on falls, like for example SRIs or short acting benzodiazepines. 相似文献
126.
Durrieu G Olivier P Montastruc JL;French networks of Pharmacovigilance centers 《European journal of clinical pharmacology》2005,61(8):611-614
Objective To evaluate the main characteristics of case reports of arterial hypertension (AH) related to COX-2 inhibitor (coxib) use in real-life practice.Methods This study was based on spontaneous reports of adverse drug reactions (ADRs) submitted to the French Pharmacovigilance system. Associations between AH and the different groups of those using non-steroidal anti-inflammatory drugs (NSAIDs: rofecoxib, celecoxib and non-selective NSAIDs) were compared using calculation of the odds ratio (OR) with 95% confidence intervals (CIs).Results In France, between 1 April 2000 and 30 November 2003, 34 AH cases related to coxibs were reported. Case reports include predominantly patients older than 65 years, with a previous story of essential AH. Most AH (60%) occurred during the first 15 days of treatment. The AH was reported significantly more frequently for rofecoxib than celecoxib. The OR for development of AH with rofecoxib versus celecoxib was 3.3 (1.6–6.9). The AH was also reported more frequently with coxib (2.8%) than with non-selective NSAID (0.5%) use, OR = 5.9 (3.8–9.0).Conclusion This study shows that coxibs are associated with a risk of AH in real-life practice. More spontaneous reports of AH to the French Pharmacovigilance system concern rofecoxib than celecoxib (and coxibs than non-selective NSAIDs). This ADR is of special epidemiological importance due to both the risks of AH and the large use of coxibs. 相似文献
127.
128.
Background
In 2002, the World Health Organization published a health system performance ranking for 191 member countries. The ranking was based on five indicators, with fixed weights common to all countries.Methods
We investigate the feasibility and desirability of using mathematical programming techniques that allow weights to vary across countries to reflect their varying circumstances and objectives.Results
By global distributional measures, scores and ranks are found to be not very sensitive to changes in weights, although differences can be large for individual countries.Conclusions
Building the flexibility of variable weights into calculation of the performance index is a useful way to respond to the debates and criticisms appearing since publication of the ranking. 相似文献129.
130.
Dugué A Bagheri H Lapeyre-Mestre M Tournamille JF Sailler L Dedieu G Salvayre R Thouvenot JP Massip P Montastruc JL 《European journal of clinical pharmacology》2004,60(4):285-292
Aims The awareness of muscular adverse drug reactions (ADRs) increased since the withdrawal of cerivastatin, a HMG-CoA reductase inhibitor, from the market in August 2001. Our objectives were to assess the detection and incidence of muscular ADRs in a University Hospital using biochemical laboratory data and to evaluate the underreporting rate of drug-induced muscular disorders.Methods A prospective study was undertaken at Toulouse University Hospital, France, for 1 week per month from November 2001 to October 2002. Patients were selected by means of a computerized process using biochemical laboratory data based on serum creatine phosphokinase (CPK) values (over twofold normal). Medical records of all selected patients were then consulted.Results During the period of the study, 2017 CPK tests were performed, among which 171 values were over twofold normal corresponding to 129 patients. Because of lack of data, 26 patients were excluded. Among these patients (n=103), 28 cases of muscular ADRs were suspected, 22 of which were detected in outpatient departments. Four patients were totally asymptomatic and five had an increase of CPK over fivefold normal. Nine cases were classified as serious. Withdrawal of suspected drugs were done in 16 cases with regression of ADRs in 13 cases. According to hospitalization data, the incidence of muscular ADRs was estimated as 7.2 (2.6–15.7) per 10,000 inpatients and 9.3 (5.8–14.1) per 10,000 outpatients over 12 weeks. The involved drugs were mainly: statins (46.4%), fibrates (14.3%), antiretrovirals (14.3%), angiotensin-II receptor antagonists (10.7%), immunosuppressants (7.1%) or hydroxychloroquine (7.1). Only two cases, judged as serious, were spontaneously reported by physicians during the same period.Conclusion The results of this survey underline the importance to take into account drug hypothesis in muscular injuries diagnosis. 相似文献